Clinical Trial Update: An Exploratory Study to Characterise Changes in Airway Inflammation, Symptoms, Lung Function and Reliever Use in Adult Asthma Patients [Phase 4]

View source ↗

Summary

A Phase 4 exploratory study sponsored by AstraZeneca in adult asthma patients to characterize airway inflammation, symptoms, lung function and reliever use, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: AstraZeneca | Conditions: Airway Inflammation, Asthma | Phase 4 | Status: COMPLETED | Results posted: 2025-01-22